OpenLB
Open Library of Bioscience
Advanced Search
Infectious disease clinics of North America
Dec, 2004;18 (4): 993-1016, xi.

Antimicrobial therapy of community-acquired pneumonia.

Thomas M File, Michael S Niederman
Author Information
  1. Thomas M File: Summa Health System, 75 Arch Street, Suite 105, Akron, OH 44304, USA. filet@summa-health.org
PMID: 15555836 DOI: 10.1016/j.idc.2004.07.011

Abstract

Community-acquired pneumonia (CAP) is a common disorder that is potentially life-threatening, especially in older adults and patients with comorbid disease. Despite substantial progress in therapeutic options, CAP remains a primary cause of death from infectious disease in the United States. The mainstay of treatment for most patients is appropriate antimicrobial therapy This article reviews the principles for initial antimicrobial therapy, highlights some of the differences in approaches to antimicrobial drug selection in selected guidelines, and includes new recommendations for empiric and pathogen-directed therapy of CAP.

References

  1. Clin Infect Dis. 2000 Aug;31(2):613-5 [PMID: 10987733]
  2. JAMA. 2003 Nov 19;290(19):2588-98 [PMID: 14625336]
  3. Clin Infect Dis. 2002 Sep 1;35(5):632; author reply 632-3 [PMID: 12173142]
  4. Arch Intern Med. 2000 May 22;160(10):1399-408 [PMID: 10826451]
  5. Lancet. 2003 Dec 13;362(9400):1991-2001 [PMID: 14683661]
  6. Clin Infect Dis. 1997 Jun;24(6):1052-9 [PMID: 9195057]
  7. Clin Infect Dis. 1999 Oct;29(4):797-800 [PMID: 10589891]
  8. Pharmacotherapy. 2001 Jul;21(7 Pt 2):79S-82S [PMID: 11446522]
  9. Clin Infect Dis. 2002 Sep 1;35(5):556-64 [PMID: 12173129]
  10. Am J Respir Crit Care Med. 2003 Jun 15;167(12):1650-4 [PMID: 12689848]
  11. Thorax. 2001 Dec;56 Suppl 4:IV1-64 [PMID: 11713364]
  12. Pediatr Infect Dis. 1986 Jan-Feb;5(1):167-71 [PMID: 3080736]
  13. Ann Pharmacother. 2000 Apr;34(4):446-52 [PMID: 10772428]
  14. Thorax. 1989 Dec;44(12):1031-5 [PMID: 2515602]
  15. Chest. 2003 May;123(5):1503-11 [PMID: 12740267]
  16. N Engl J Med. 2002 Feb 21;346(8):630-1 [PMID: 11856810]
  17. Clin Infect Dis. 2002 Apr 15;34(8):1076-83 [PMID: 11914996]
  18. Clin Infect Dis. 1999 Aug;29(2):426-8 [PMID: 10476753]
  19. J Antimicrob Chemother. 1996 Jun;37 Suppl C:115-24 [PMID: 8818852]
  20. Medicine (Baltimore). 2001 Mar;80(2):75-87 [PMID: 11307590]
  21. Curr Opin Infect Dis. 2002 Apr;15(2):163-7 [PMID: 11964918]
  22. Clin Infect Dis. 2000 Oct;31(4):1008-11 [PMID: 11049784]
  23. Arch Intern Med. 2000 May 8;160(9):1294-300 [PMID: 10809032]
  24. Am J Respir Crit Care Med. 2001 Jun;163(7):1730-54 [PMID: 11401897]
  25. N Engl J Med. 2002 Mar 7;346(10):747-50 [PMID: 11882730]
  26. Semin Respir Infect. 2001 Sep;16(3):153-4 [PMID: 11562894]
  27. Clin Infect Dis. 2003 Dec 1;37(11):1405-33 [PMID: 14614663]
  28. Eur Respir J. 1995 Mar;8(3):398-402 [PMID: 7789484]
  29. Clin Infect Dis. 2002 Sep 1;35(5):533-9 [PMID: 12173126]
  30. Semin Respir Crit Care Med. 2000;21(4):295-304 [PMID: 16088740]
  31. Antimicrob Agents Chemother. 2002 Jun;46(6):1746-54 [PMID: 12019085]
  32. Thorax. 1996 Feb;51(2):179-84 [PMID: 8711652]
  33. Chest. 2004 Apr;125(4):1343-51 [PMID: 15078744]
  34. Clin Infect Dis. 2003 Aug 1;37(3):376-81 [PMID: 12884162]
  35. Clin Infect Dis. 2002 Oct 1;35(7):819-24 [PMID: 12228818]
  36. JAMA. 2001 Oct 17;286(15):1857-62 [PMID: 11597287]
  37. Arch Intern Med. 2003 Mar 10;163(5):601-5 [PMID: 12622607]
  38. Arch Intern Med. 2003 Jul 28;163(14):1718-26 [PMID: 12885688]
  39. Clin Ther. 2002 Nov;24(11):1770-85 [PMID: 12501873]
  40. Drugs Today (Barc). 2001 Sep;37(9):617-628 [PMID: 12743633]
  41. Eur J Clin Microbiol Infect Dis. 1998 Dec;17(12):828-33 [PMID: 10052544]
  42. Clin Infect Dis. 2003 Feb 15;36(4):389-95 [PMID: 12567294]
  43. Am J Med. 1999 Jul 26;107(1A):34S-43S [PMID: 10451007]
  44. Arch Intern Med. 1999 Nov 22;159(21):2576-80 [PMID: 10573047]
  45. Arch Intern Med. 2000 Nov 27;160(21):3234-40 [PMID: 11088083]
  46. Clin Infect Dis. 2000 Aug;31(2):383-421 [PMID: 10987698]
  47. Medicine (Baltimore). 1990 Sep;69(5):307-16 [PMID: 2205784]
  48. Clin Infect Dis. 2001 Mar 1;32(5):701-7 [PMID: 11229837]
  49. Arch Intern Med. 2001 Aug 13-27;161(15):1837-42 [PMID: 11493124]
  50. Clin Infect Dis. 1998 May;26(5):1188-95 [PMID: 9597251]
  51. Chest. 2001 May;119(5):1420-6 [PMID: 11348948]
  52. JAMA. 2000 Feb 23;283(8):1016-24 [PMID: 10697061]
  53. Pharmacotherapy. 2002 Mar;22(3):395-9 [PMID: 11898897]
  54. Arch Intern Med. 2001 Aug 13-27;161(15):1866-72 [PMID: 11493128]
  55. Arch Intern Med. 2001 Nov 26;161(21):2538-44 [PMID: 11718584]
  56. Am J Med. 1996 Nov;101(5):508-15 [PMID: 8948274]
  57. Clin Infect Dis. 2003 Jul 15;37(2):230-7 [PMID: 12856216]
  58. Arch Intern Med. 1999 Nov 22;159(21):2562-72 [PMID: 10573046]
  59. Clin Infect Dis. 2002 Mar 1;34 Suppl 1:S17-26 [PMID: 11810607]
  60. Clin Infect Dis. 2003 May 1;36(9):1132-8 [PMID: 12715307]
  61. Arch Intern Med. 2002 Sep 9;162(16):1849-58 [PMID: 12196083]
  62. Curr Clin Top Infect Dis. 1999;19:112-34 [PMID: 10472483]
  63. Clin Infect Dis. 2003 Oct 15;37(8):1050-8 [PMID: 14523769]
  64. JAMA. 1999 Oct 6;282(13):1240-6 [PMID: 10517426]
  65. Antimicrob Agents Chemother. 2000 Jul;44(7):1796-802 [PMID: 10858333]
  66. Clin Infect Dis. 2003 Sep 15;37(6):752-60 [PMID: 12955634]
  67. Scand J Infect Dis. 1994;26(6):706-10 [PMID: 7747094]
  68. Am J Respir Crit Care Med. 1999 Sep;160(3):923-9 [PMID: 10471620]

MeSH Term

Ambulatory Care
Anti-Bacterial Agents
Bacteria
Community-Acquired Infections
Drug Administration Schedule
Drug Resistance, Multiple, Bacterial
Drug Utilization
Hospitalization
Humans
Pneumonia, Bacterial
Practice Guidelines as Topic

Chemicals

Anti-Bacterial Agents
Journal Article Review
Article has an altmetric score of 3

Word Cloud

Created with Highcharts 10.0.0therapyCAPantimicrobialpneumoniapatientsdiseaseCommunity-acquiredcommondisorderpotentiallylife-threateningespeciallyolderadultscomorbidDespitesubstantialprogresstherapeuticoptionsremainsprimarycausedeathinfectiousUnitedStatesmainstaytreatmentappropriatearticlereviewsprinciplesinitialhighlightsdifferencesapproachesdrugselectionselectedguidelinesincludesnewrecommendationsempiricpathogen-directedAntimicrobialcommunity-acquired

Similar Articles

Cited By